1. Capeless EL, Clapp JF. Cardiovascular changes in early phase of pregnancy.
Am J Obstet Gynecol. 1989;161:1449.
[PubMed: 2603897]
2. Clapp JF. Maternal heart rate in pregnancy.
Am J Obstet Gynecol. 1985;152:659.
[PubMed: 4025424]
3. Moertl MG, Ulrich D, Pickel KI, et al. Changes in haemodynamic and autonomous nervous system parameters measured non-invasively throughout normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 2009;144:S179.
4. Lindheimer MD, August P. Aldosterone, maternal volume status and healthy pregnancies: a cycle of differing views.
Nephrol Dial Transplant. 2009;24:1712.
[PubMed: 19258387]
5. Sarfat R, Maechaud M, Magnin G. Comparison of blood loss during cesarean section and during vaginal delivery with -episiotomy. J Gynecol Obstet Biol Reprod. 1999;28:48.
6. Leighton BL, Norris MC, DeSimone CA, et al. Pre-eclamptic and healthy term pregnant patients have different chronotropic responses to
isoproterenol.
Anesthesiology. 1990;72:392.
[PubMed: 2301776]
7. Grant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnant. J Clin Invest. 1973;52:2682.
8. Weiner C, Liu KZ, Thompson L, Herrig J, Chestnut D. Effect of pregnancy on endothelium and smooth muscle: their role in reduced adrenergic sensitivity. Am J Physiol. 1991;261:H1275.
9. Camorcia M. Testing the epidural catheter.
Curr Opin Anaesthesiol. 2009;22:336.
[PubMed: 19342949]
10. Howard BK, Goodson JH, Mengert WF. Supine hypotension syndrome in late pregnancy.
Obstet Gynecol. 1953;1:371.
[PubMed: 13055188]
11. Lees MM, Taylor SH, Scott DB, et al. A study of cardiac output at rest throughout pregnancy.
J Obstet Gynaecol Br Commonw. 1967;74:319.
[PubMed: 6026611]
12. Uleland K, Novy MJ, Peterson EN, et al. Maternal cardiovascular dynamics. IV. The influence of gestational age on the maternal cardiovascular response to posture and exercise. Am J Obstet Gynecol. 1969;104:856.
13. Cohen SE, Andes LC, Carvalho B. Assessment of knowledge regarding cardiopulmonary resuscitation of pregnant women.
Int J Obstet Anesth. 2008;17:20.
[PubMed: 18162200]
14. Enein M, Zina AA, Kassem M, et al. Echocardiography of the pericardium in pregnancy.
Obstet Gynecol. 1987;69:851.
[PubMed: 3574815]
15. Dobb G. Laryngeal oedema complicating obstetric anaesthesia.
Anaesthesia. 1978;33:839.
[PubMed: 717739]
16. Pilkington S, Carli F, Dakin MJ, et al. Increase in Mallampati score during pregnancy.
Br J Anaesth. 1995;74:638.
[PubMed: 7640115]
17. Ezri T, Szmuk P, Evron S, et al. Difficult airway in obstetric anesthesia: a review.
Obstet Gynecol Surv. 2001;56:631.
[PubMed: 11590314]
18. Archer GW, Marx GF. Arterial
oxygen tension during apnoea in parturient women.
Br J Anaesth. 1974;6:358.
19. Norris MC, Dewan DM. Preoxygenation for cesarean -section: a comparison of two techniques.
Anesthesiology. 1985;62:827.
[PubMed: 4003814]
20. Jensen D, Webb KA, O'Donnell DE. Chemical and mechanical adaptations of the respiratory system at rest and during exercise in human pregnancy.
Appl Physiol Nutr Metab. 2007;32:1239.
[PubMed: 18059602]
21. Varner MW. Physiologic changes in normal pregnancy. Iowa Perinatol Lett. 1985;6:1.
22. Cotton DB, Gonik B, Spillman T, et al. Intrapartum post–partum changes in colloid osmotic pressure.
Am J Obstet Gynecol. 1984;149:174.
[PubMed: 6720795]
23. Chiloiro M, Darconza G, Piccioli E, DeCarmen M, Clemente C, Riezzo G. Gastric emptying and orocecal transit time in pregnancy.
J Gastroenterol. 2001;36:538.
[PubMed: 11519832]
24. Hong JY, Park JW, Oh JI. Comparison of preoperative gastric contents and serum gastrin concentrations in pregnant and nonpregnant women.
J Clin Anesth. 2005;17:451.
[PubMed: 16171666]
25. Shnider SM. Serum cholinesterase activity during pregnancy, labor, and puerperium.
Anesthesiology. 1965;26:335.
[PubMed: 14289955]
27. Whittaker PG, Macphail S, Lind T. Serial hematologic changes and pregnancy outcome.
Obstet Gynecol. 1996;88:33.
[PubMed: 8684758]
28. Hellgren M. Hemostasis during normal pregnancy and puerperium.
Semin Thromb Hemost. 2003;29:125.
[PubMed: 12709915]
29. James AH. Pregnancy-associated thrombosis. Hematology Am Soc Hematol Educ Program. 2009;277.
30. Bernasko J. Contemporary management of type I diabetes mellitus in pregnancy.
Obstet Gynecol Surv. 2004;59:628.
[PubMed: 15277897]
31. Rasmussen KM, Yaktine AL, eds.; Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC: National Academies Press; 2009:3.
32. Cararach V, Carmona F, Monleon FJ, et al. Pregnancy after renal transplantation: 25 years experience in Spain.
Br J Obstet Gynaecol. 1993;100:122.
[PubMed: 8476801]
33. Muallem MM, Rubeiz NG. Physiological and biological skin changes in pregnancy.
Clin Derm. 2006;24:80.
[PubMed: 16487877]
34. Oatridge A, Holdcroft A, Saeed N, et al. Change in brain size during and after pregnancy: study in healthy women and women with preeclampsia.
AJNR Am J Neuroradiol. 2002;23:19.
[PubMed: 11827871]
35. Palahniuk RJ, Shnider SM, Eger EI. Pregnancy decreases the requirements for inhaled anesthetic agents.
Anesthesiology. 1974;41:82.
[PubMed: 4857789]
36. Datta S, Lambert DH, Gregus J, et al. Differential sensitivities of mammalian nerve fibers during pregnancy.
Anesth Analg. 1983;62:1070.
[PubMed: 6650889]
37. Fagraeus L, Urban B, Bromage P. Spread of epidural analgesia in early pregnancy.
Anesthesiology. 1983;58:184.
[PubMed: 6824173]
38. Curtin SC. Recent changes in birth attendant, place of birth, and the use of obstetric interventions: United States, 1989-1997.
J Nurse Midwifery. 1999;44:349.
[PubMed: 10466281]
39. Farley D, Dudley DJ. Fetal assessment during pregnancy.
Pediatr Clin North Am. 2009;56:489.
[PubMed: 19501688]
40. Macones GA, Hankins GDV, Spong CY, Hauth J, Moore T. The 2008 National Institute of Child Health and Human Development Workshop Report on Electronic Fetal Moni-toring: Update on Definitions, Interpretation, and Research Guide-lines.
J Obstet Gynecol Neonatal Nurs. 2008;37:510.
[PubMed: 18761565]
41. Luthy DA, Shy KK, Van Belle G, et al. A randomized trial of electronic fetal monitoring in preterm labor.
Obstet Gynecol. 1987;69:687.
[PubMed: 3554055]
42. Pearson JF, Weaver JB. Fetal activity and fetal well-being: an evaluation.
Br Med J. 1976;1:1305.
[PubMed: 1268677]
43. Evertson LR, Gauthier RJ, Schifrin BS, et al. Antepartum fetal heart rate testing: evolution of the nonstress test.
Am J Obstet Gynecol. 1979;133:29.
[PubMed: 760532]
44. Huddleston JF, Sutliff G, Robinson D. Contractions stress test by intermittent nipple stimulation.
Obstet Gynecol. 1984; 63:669.
[PubMed: 6717870]
45. Freeman RK, Anderson G, Dorchester W. A prospective multi-institutional study of antepartum fetal monitoring. Risk of perinatal mortality and morbidity according to antepartum fetal heart rate tests.
Am J Obstet Gynecol. 1982;143:771.
[PubMed: 7102744]
46. Manning FA, Morrison I, Lange IR, Harman CR, Chamberlain PF. Fetal biophysical profile scoring; selective use of the nonstress test.
Am J Obstet Gynecol. 1987;156:709.
[PubMed: 3548386]
47. Kim SY, Shandelwal M, Gaughan JP, Agar MH, Reece EA. Is the intrapartum biophysical profile useful.
Obstet Gynecol. 2003;102:471.
[PubMed: 12962926]
48. Reuwer PJ, Bruinse HW, Stoutenbeek T. Doppler assessment of the fetoplacental circulation in normal and growth-retarded fetuses.
Eur J Obstet Gynecol Reprod Biol. 1984;18:199.
[PubMed: 6240422]
49. Vintzileos AM, Nioka S, Lake M, et al. Transabdominal fetal pulse oximetry with near-infrared spectroscopy.
Am J Obstet Gynecol. 2005;192:129.
[PubMed: 15672014]
50. Bryant AS, Worjoloh A, Caughey AB, Washington AE. Racial/ethnic disparities in obstetric outcomes and care: prevalence and determinants.
Am J Obstet Gynecol. 2010;202:335.
[PubMed: 20060513]
51. Hack M, Fanaroff AA. Outcomes of extremely immature infants: a perinatal dilemma.
N Engl J Med. 1993;329:1649.
[PubMed: 8232435]
52. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity.
N Engl J Med. 1985;312:82.
[PubMed: 3880598]
53. Behrman RE, Butler AS; Institute of Medicine (U.S.); Committee on understanding premature birth and assuring health outcomes. Institute of Medicine (U.S.); Board of Health Sciences Policy. Preterm Birth: Causes, Consequences, and Prevention. Washington, DC: National Academies Press; 2006.
54. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery.
N Engl J Med. 2000;342:1500.
[PubMed: 10816189]
56. McDonald HM, O'Loughlin JA, Vignoswaran L, et al. Impact of
metronidazole therapy on preterm birth in women with -bacterial vaginosis flora: a randomized, placebo controlled trial.
Br J Obstet Gynaecol. 1997;104:139.
57. Macones GA, Parry S, Elsousy M, et al. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth.
Am J Obstet Gynecol. 2004;190:1504.
[PubMed: 15284722]
58. Romero R, Kuivaniemi H, Tromp G. Functional genomics and proteomics in term and preterm parturition.
J Clin Endocrinol Metab. 2002;87:2431.
[PubMed: 12050194]
59. Ingemarrson I, Lamont RF. An update on the controversies of tocolytic therapy for the prevention of preterm birth. Acta Obstet Gynecol Scand. 2003;82:1.
60. Berkman ND, Thorp JM Jr, Lohr KN, et al. Tocolytic treatment for the management of preterm labor: a review of the evidence.
Am J Obstet Gynecol. 2002;186:587.
[PubMed: 11904629]
61. ACOG Practice Bulletin No 43: Management of preterm labor, Vol 101. Obstet Gynecol. 2003;5:1039.
62. Mercer BM, Merlino AA. Magnesium sulfate for preterm labor and preterm birth.
Obstet Gynecol. 2009;114:650.
[PubMed: 19701047]
63. Doyle LW, Crowther CA, Middleton P, Marret S. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.
Obstet Gynecol. 2009;113:1327.
[PubMed: 19461430]
64. Hayes E, Moroz K, Pizzi L, Baxter J. A cost decision analysis of 4 tocolytic drugs.
Am J Obstet Gynecol. 2007;197:383e1.
[PubMed: 17904969]
65. Moise KJ. The effect of advancing gestational age on the frequency of ductal constriction secondary to maternal
indomethacin use.
Am J Obstet Gynecol. 1993;168:1350.
[PubMed: 8498410]
66. Romero R, Sibai BM, Sanchez-Ramos L, et al. An
oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double blind, placebo-controlled trial with tocolytic rescue.
Am J Obstet Gynecol. 2000;182:1173.
[PubMed: 10819855]
67. Sanches Ramos L, Kiunitz AM, Gauder Fl, et al. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am J Obstet Gynecol. 1999;181:484.
68. Sibai B, Dakker G, Kupferminc M. Preeclampsia.
Lancet. 2005;365:785.
[PubMed: 15733721]
69. Report of the National High Blood Pressure Education Program. Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1.
70. Hauth JC, Ewell MG, Levine RL, et al. Pregnancy outcomes in healthy nulliparous women who subsequently developed hypertension.
Obstet Gynecol. 2000;95:24.
[PubMed: 10636496]
71. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102;181.
72. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia.
Ann Rev Pathol Mech Dis. 2010;5:173.
[PubMed: 20078220]
73. Lie RT, Rasmussen S, Brumborg H, et al. Fetal and maternal contributions to risk of preeclampsia: population based study.
BMJ. 1998;316:1343.
[PubMed: 9563982]
74. Skjaerven R, Vatten LJ, Wilcox AJ, et al. Recurrence of preeclampsia across generations: exploring fetal and maternal genetic components: a population based cohort.
BMJ. 2005;331:877.
[PubMed: 16169871]
75. Baumann MV, Bersinger NA, Surbeck DV. Serum markers for predicting preeclampsia.
Mol Aspects Med. 2007;28:227.
[PubMed: 17532461]
76. Smith GCS, Wear H. The perinatal implications of angiogenic factors.
Curr Opin Obstet Gynecol. 2009;21:111.
[PubMed: 19996864]
77. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
N Engl J Med. 2006;355:992.
[PubMed: 16957146]
78. Masuyama H, Nakatsukasa H, Takamoto N, et al. Correlation between soluble endoglin, vascular endothelial growth -factor receptor-1, and adipocytokines in preeclampsia.
J Clin Endocrin Metabol. 2007;92:2672.
[PubMed: 17426083]
79. McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses.
Am Heart J. 2008;156:918.
[PubMed: 19061708]
80. Magpie Trial Collaborative Group. Do women with preeclampsia and their babies benefit from magnesium sulfate? The Magpie Trial: a randomized placebo-controlled trial. Lancet. 2002;359:1877.
81. Livingston JC, Livingston LW, Ramsey R, Mabie BC, Sibai BM. Magnesium sulfate in women with mild preeclampsia: a -randomized controlled trial.
Obstet Gynecol. 2003;101:217.
[PubMed: 12576241]
82. Witlin AG, Friedman SA, Sibai BM. The effect of magnesium sulfate on the duration of labor in women with mild preeclampsia: a randomized double blind placebo controlled trial.
Am J Obstet Gynecol. 1997;176:623.
[PubMed: 9077617]
83. Caritis S, Sibai B, Lindheimer MD, et al. Low dose
aspirin to prevent preeclampsia in women at high risk.
N Engl J Med. 1998;338:701.
[PubMed: 9494145]
84. Coomarasamy A, Honest H, Papacoannou S, Gee H, Khan KS.
Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review.
Obstet Gynecol. 2003;101:1319.
[PubMed: 12798543]
85. Abalos E, Duley L, Steyn DW, Henderson DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2001;1:2252.
86. Lindheimer MD, Katz AI. Current concepts: hypertension in pregnancy.
N Engl J Med. 1985;313:675.
[PubMed: 3894964]
87. Graham C, Goldstein A. Epidural analgesia and cardiac output in severe preeclampsia.
Anaesthesia. 1980;35:709.
[PubMed: 7435938]
88. Newsome LR, Bramwell RS, Curling PE. Severe preeclampsia: hemodynamic effects of lumbar epidural anesthesia.
Anesth Analg. 1986;65:31.
[PubMed: 3940467]
89. Visalyaputra S, Rodanant O, Somboonviboon W, et al. Spinal versus epidural anesthesia for cesarean delivery in severe pre-eclampsia: a prospective, randomized multicenter study.
Anesth Analg. 2005;101:862.
[PubMed: 16116005]
90. Jouppila P, Jouppila R, Hollmen A, et al. Lumbar epidural analgesia to improve intervillous blood flow during labor in severe preeclampsia.
Obstet Gynecol. 1982;59:158.
[PubMed: 7078860]
91. Abboud T, Artal R, Sarkis F, et al. Sympathoadrenal activity: maternal, fetal, and neonatal responses after epidural anesthesia in the preeclamptic patient.
Am J Obstet Gynecol. 1982;144:915.
[PubMed: 7148923]
92. Hodgkinson R, Husain FJ, Hayashi RH. Systemic and pulmonary blood pressure during caesarean section in parturients with gestational hypertension.
Can Anaesth Soc J. 1980;27:389.
[PubMed: 7407669]
93. Heller PJ, Scheider EP, Marx GP. Pharyngolaryngeal edema as a presenting symptom in preeclampsia.
Obstet Gynecol. 1983;62:523.
[PubMed: 6888832]
94. Pitkin R, Witte D. Platelet and leukocyte counts in pregnancy.
JAMA. 1979.242:2696.
[PubMed: 501868]
95. O'Brien JR. Platelet count in normal pregnancy.
J Clin Pathol. 1976;29:174.
[PubMed: 932218]
96. Rakocai I, Tallian R, Bagdany S, Gati I. Platelet life-span in normal pregnancy and pre-eclampsia as determined by a non-radioisotope technique. Thromb Res. 1979;15:553.
97. Roberts WE, Perry KG Jr, Woods JB, et al. The intrapartum platelet count in patients with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome: is it predictive of later hemorrhagic complications?
Am J Obstet Gynecol. 1994;171:799.
[PubMed: 8092232]
98. Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancy-related mortality surveillance—United States. 1991-1999. MMWR Surveill Summ. 2003;52:S2.
99. Bahar A, Abusham A, Eskandar M, Sobande A, Alsunaidi M. Risk factors and pregnancy outcome in different types of placenta previa.
J Obstet Gynaecol Can. 2009;31:126.
[PubMed: 19327211]
100. Vergani P, Ornaghi S, Pozzi I, et al. Placenta previa: distance to internal os and mode of delivery.
Am J Obstet Gynecol. 2009;201:266.e1.
[PubMed: 19631924]
101. Yang Q, Wen SW, Phillips K, Oppenheimer L, Black D, Walker MC. Comparison of maternal risk factors between placental abruption and placenta previa.
Am J Perinatol. 2009;26:279.
[PubMed: 19021090]
102. Pahlavan P, Nezhat C, Nezhat C. Hemorrhage in obstetrics and gynecology.
Curr Opin Obstet Gynecol. 2001;13:419.
[PubMed: 11452205]
103.
Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries.
Obstet Gynecol. 2006;107:1226.
[PubMed: 16738145]
104. Ananth CV, Oyelese Y, Yeo L, Pradham A, Vintzileos AM. Placental abruption in the United States, 1979 through 2001: temporal trends and potential determinants.
Am J Obstet Gynecol. 2005;192:191.
[PubMed: 15672024]
105. Witlin AG, Saade GR, Mattar F, Sibai BM. Risk factors for abruption placentae and eclampsia: analysis of 445 consecutively managed women with severe preeclampsia and eclampsia.
Am J Obstet Gynecol. 1999;180:1322.
[PubMed: 10368466]
106. Nyburg DA, Cyn DR, Mack LA, et al. Sonographic spectrum of placental abruption. AJR. 1987;148:161.
107. Augustin G, Majerovic M. Non-obstetrical acute abdomen during pregnancy.
Eur J Obstet Gynecol Reprod Biol. 2007;131:4.
[PubMed: 16982130]
108. Shnider SM, Webster GM. Maternal and fetal hazards of surgery during pregnancy.
Am J Obstet Gynecol. 1965;92:891.
[PubMed: 14321105]
109. Brodsky JB, Cohen EN, Brown BW Jr, et al. Surgery during pregnancy and fetal outcome.
Am J Obstet Gynecol. 1980;138:1165.
[PubMed: 7446625]
110. Duncan PG, Pope WD, Cohen MM, Greer N. Fetal risk of anesthesia and surgery during pregnancy.
Anesthesiology. 1986;64:790.
[PubMed: 3717642]
111. Mazze RI, Kallen B. Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases.
Am J Obstet Gynecol. 1989;161:1178.
[PubMed: 2589435]
112. Czeizel AE, Pataki T, Rockenbauer M. Reproductive outcome after exposure to surgery under anesthesia during pregnancy.
Arch Gynecol Obstet. 1998;261:193.
[PubMed: 9789650]
113. Kallen B, Mazze RI. Neural tube defects and first trimester operations.
Teratology. 1990;41:717.
[PubMed: 2353318]
114. Sylvester GC, Khoury MJ, Lu X, Erickson JD. First trimester anesthesia exposure and the risk of central nervous system defects: a population-based case-control study.
Am J Public Health. 1994;84:1757.
[PubMed: 7977913]
115. Kendrick JM, Woodard CB, Cross SB. Surveyed use of fetal and uterine monitoring during maternal surgery. AORN J. 1995;62:360.
116. ACOG: Committee Opinion #284. Nonobstetric surgery in pregnancy. Obstet Gynecol. 2003;102:431.
117. Siu SC, Sermer M, Colam JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease.
Circulation. 2001;104:515.
[PubMed: 11479246]
118. Whittemore R, Hobbins J, Engle M. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease.
Am J Cardiol. 1982;50:641.
[PubMed: 7113941]
119. Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease.
Circulation. 1997;96:2789.
[PubMed: 9386139]
120. Siu SC, Colman JM. Heart disease and pregnancy.
Heart. 2001;85:710.
[PubMed: 11359761]
121. Ben Farhet M, Ganra H, Betbout F, et al. Percutaneous balloon mitral commissurotomy during pregnancy. Heart. 1997;77:564.
122. Autoe C, Conte MR, Piccininno M, et al. Risk associated with pregnancy in hypertropic cardiomyopathy. J Am College Cardiol. 2002;40:1864.
123. Patel An Asopa S, Tang ATM, Ohri SK. Cardiac surgery during pregnancy.
Tex Heart Inst J. 2008;35:307.
[PubMed: 18941609]
124. Shime J, Mocarski EJ, Hastins D, Webb GD, McLaughlin PR. Congenital heart disease in pregnancy: short- and long-term implications.
Am J Obstet Gynecol. 1987;156:313.
[PubMed: 3826166]
125. Veille JC. Peripartum cardiomyopathies: a review.
Am J Obstet Gynecol. 1984;148:805.
[PubMed: 6367478]
126. Elkayan U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med. 2001;344:1567.
127. Chaithiraphan V, Gowda RM, Khan IA, Remos CD. Peripartum acute myocardial infarction: management perspective.
Am J Ther. 2003;10:75.
[PubMed: 12522527]
128. Bonnin M, Mercier FJ, Sitbon O, et al. Severe pulmonary hypertension during pregnancy.
Anesthesiology. 2005;102:1133.
[PubMed: 15915025]
129. Schatz M. The efficacy and safety of asthma medications during pregnancy.
Semin Perinatol. 2001;25:145.
[PubMed: 11453610]
130. Schatz M. Interrelationships between asthma and pregnancy: a literature review. J Allergy Clin Immunol. 1999;103:S330.
131. Kwon H, Belanger K, Bracken B. Effect of pregnancy and stage of pregnancy on asthma severity: a systematic review.
Am J Obstet Gynecol. 2004;190:1201.
[PubMed: 15167819]
132. Harirah HM, Donia S, Masrallah F, Saade G, Belfort M. Effect of gestational age and position on peak expiratory flow: a -longitudinal study.
Obstet Gynecol. 2005;105:372.
[PubMed: 15684167]
133. Sorensen TK, Dempsey JC, Xiao R, et al. Maternal asthma and risk of preterm delivery.
Ann Epidemiol. 2003;13:267
[PubMed: 12684193]
134. Clifton VL, Engel P, Smith R, Gibson P, Brinsmead M, Giles WB. Maternal and neonatal outcomes of pregnancies complicated by asthma in an Australian population.
Aust N Z J Obstet Gynaecol. 2009;49:619.
[PubMed: 20070710]
135. Triche E, Saftlas A, Belanger K, Leaderer B, Bracken MB. Association of asthma diagnosis, severity, symptoms, and treatment with risk of preeclampsia.
Obstet Gynecol. 2004;104:585.
[PubMed: 15339773]
136. Liu S, Wen SW, Demissie L, Marcoux S, Kramer MS. Maternal asthma and pregnancy outcomes: a retrospective cohort study.
Am J Obstet Gynecol. 2001;184:90.
[PubMed: 11174486]
137. Newman RB, Momirova V, Dombrowski MMP, et al. The effect of active and passive household cigarette smoke exposure on pregnant women with asthma.
Chest. 2010;137:601.
[PubMed: 19820079]
138. Gluck JC, Cluck PA. Asthma controller therapy during pregnancy.
Am J Obstet Gynecol. 2005;192:369.
[PubMed: 15695974]
139. Blais L, Beauchesne MF, Lemiere C, Elftouh N. High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations.
J Allergy Clin Immunol. 2009;124:1229.
[PubMed: 19910032]
140. Busse WW; National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program; Asthma and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment—2004 update. J Allergy Clin Immunol. 2005;115:34.
142. Rayburn WF, Atkinson BP, Gilbert D, Turnbull GL. Short-term effects of inhaled
albuterol on maternal and fetal circulations.
Am J Obstet Gynecol. 1994;171:770.
[PubMed: 8092227]
143. Kristiansson P, Svaerdsudd K, von Schoultz B. Back pain -during pregnancy: a prospective study.
Spine. 1996;21:702.
[PubMed: 8882692]
144. Wang SM, Dexinno P, Maranets I, et al. Low back pain -during pregnancy: prevalence, risk factors, and outcomes.
Obstet Gynecol. 2004;104:65.
[PubMed: 15229002]
145. Licciardone JC, Buchanan S, Hensel KL, King HH, Fulda KG, Stoll ST. Osteopathic manipulative treatment of back pain and related symptoms during pregnancy: a randomized controlled trial.
Am J Obstet Gynecol. 2010;202:43.e1.
[PubMed: 19766977]
146. Kristiansson P, Nilsson-Wikmar K, Von Schoultz B, Svaerdsudd K, Wramsby H. Back pain in in-vitro fertilized and spontaneous pregnancies. Hum Reprod. 1998;91:182.
147. Bryhildsen J, Hansson A, Persson A, Hammar M. Follow-up of patients with low-back pain during pregnancy. Obstet Gynecol. 1998;91:182.
148. Borg-Stein J, Dugan S, Gruber J. Musculoskeletal aspects of pregnancy.
Am J Phys Med Rehabil. 2005;84:180.
[PubMed: 15725792]
149. Engelgau MM, Herman WH, Smith PJ, German RR, Aubet MRE. The epidemiology of diabetes and pregnancy in the United States, 1988.
Diabetes Care. 1995;18:1029.
[PubMed: 7555537]
150. Hedderson MM, Gunderson EP, Ferrara A. Gestational weight gain and risk of gestational diabetes mellitus.
Obstet Gynecol. 2010;115:597.
[PubMed: 20177292]
151. Mills JL, Simpson JL, Driscoll SG, et al. Diabetes in early pregnancy study: incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception.
N Engl J Med. 1988;319:1617.
[PubMed: 3200277]
152. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers.
N Engl J Med. 1981;304:1331.
[PubMed: 7012627]
153. Leperca J, Le Meaux P, Agman A, Timsit J. Factors associated with cesarean delivery in nulliparous women with type 1 -diabetes. Obstet Gynecol. 2010;115:1014.
154. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol. 2010;255:e1.
155. White P. Pregnancy complicating diabetes. Am J Med. 1949;609.
156. Dewitt DE, Hirsch IB. Outpatient
insulin therapy in type 1 and type 2 diabetes mellitus.
JAMA. 2003;289:2254.
[PubMed: 12734137]
157. Magee MS, Walden CE, Benedetti TJ, Knopp RH. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity.
JAMA. 1993;269:609.
[PubMed: 8421365]
158. Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus.
JAMA. 1997;278:1078.
[PubMed: 9315766]
159. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes.
Diabetes Care. 2002;25:1862.
[PubMed: 12351492]
160. Langer O, Conway DL, Berkus MD, et al. A comparison of -glyburide and
insulin in women with gestational diabetes -mellitus.
N Engl J Med. 2000;343:1134.
[PubMed: 11036118]
161. Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes.
N Engl J Med. 2009;361:1339.
[PubMed: 19797280]
162. Moore LE, Clokey D, Rappaport VJ, Curet LB.
Metformin compared with
glyburide in gestational diabetes: a randomized controlled trial.
Obstet Gynecol. 2010;115:55.
[PubMed: 20027034]
163. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey.
Clin Endocrinol. 1995;43:55.
[PubMed: 7641412]
164. Fantz CR, Dagogo-Jack S, Ladenson JH, Gronowski AM. Thyroid function during pregnancy.
Clin Chem. 1999;45:2250.
[PubMed: 10585360]
165. Davis LE, Leveno KJ, Cunningham FG. Hypothyroidism complicating pregnancy.
Obstet Gynecol. 1988;72:108.
[PubMed: 3380497]
166. Gaertner R. Thyroid diseases in pregnancy. Curr Opin Obstet Gynecol. 2009;21:501.
167. Poppe K, Glinoer D. Thyroid autoimmunity and hypothyroidism before and during pregnancy.
Hum Reprod Update. 2003;9:149.
[PubMed: 12751777]
168. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy.
J Clin Endocrinol Metab. 2010;95:1699.
[PubMed: 20130074]
169. Goodwin TM, Montoro M, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects.
Am J Obstet Gynecol. 1992;167:648.
[PubMed: 1382389]
170. Carranza-Lira S, Hernandez F, Sanchez M, et al. Prolactin secretion in molar and normal pregnancy.
Int J Gynecol Obstet. 1998;60:137.
[PubMed: 9509951]
171. Slmario CV, Moskowitz EJ, Koran J, et al. Examining the effectiveness of an opt-in approach to prenatal human immunodeficiency virus screening. Am J Obstet Gynecol. 2010;159:e1.
172. Watts DH. Effect of pregnancy. J AIDS. 2005;38:S36.
173. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with
zidovudine treatment. Pediatric AIDS clinical trials group protocol 076 study group.
N Engl J Med. 1994;331:1173.
[PubMed: 7935654]
174. Cooper ER, Nugent RP, Diaz C, et al. After AIDS clinical trial 076: the changing pattern of the
zidovudine use during pregnancy and the subsequent reduction in vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants.
J Infect Dis. 1996;174:1207.
[PubMed: 8940210]
175. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission.
J AIDS. 2002;29:484.
[PubMed: 11981365]
176. Miles DJC, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guerin (
BCG) vaccine in HIV-uninfected infants.
Immunology. 2009;129:446.
[PubMed: 20002789]
177. Kind C, Rudin C, Siegrist CA, et al. Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and
zidovudine prophylaxis.
AIDS. 1998;12:205.
[PubMed: 9468370]
178. Madelbrot L, Le Chenadec J, Berrebi A, et al. Perinatal HIV-1 transmission: interaction between
zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort.
JAMA. 1998;280:55.
179. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immuno-deficiency virus type 1. N Engl J Med. 1999;340:977.
180. The American College of Obstetricians and Gynecologists. Scheduled Cesarean Delivery and the Prevention of Vertical Transmission of HIV Infection. Committee opinion #234, Washington, DC: American College of Obstetricians and Gynecologists; 2000.
181. Mater C, Warren WB, Moomgy M, Fink DJ, Fox HE. Prevalence of use of
cocaine and other substances in the obstetric population.
Am J Obstet Gynecol. 1990;63:797.
182. Towers CV, Pircon RA, Nageotte MP, Porto M, Garite TJ.
Cocaine intoxication presenting as preeclampsia and eclampsia.
Obstet Gynecol. 1993;81:545.
[PubMed: 8459963]
183. Strathearn L, Mayes LC.
Cocaine addiction in mothers: potential effects on maternal care and infant development.
Ann NY Acad Sci. 2010;1187:172.
[PubMed: 20201853]
184. Ackerman JP, Riggings T, Black MM. A review of the effects of prenatal
cocaine exposure among school-aged children.
Pediatrics. 2010;125:554.
[PubMed: 20142293]
185. Kain ZN, Mayes LC, Ferris CA, Pakes J, Schottenfeld R. Cocaine-abusing parturients undergoing cesarean section: a cohort study.
Anesthesiology. 1996;85:1028.
[PubMed: 8916819]